关键数据
1.160今开
1.175最高
2.41K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.01%换手率
1.170昨收
1.150最低
2.80K成交额
亏损市盈率静
4.20市净率
0.00%股息率 TTM
-63.14%ROA
1.57052周最高
0.02量比
-13.00M净利润
51.90M总股本
-0.2748每股收益TTM
0.77Beta
-118.40%ROE
0.68752周最低
2.56%振幅
100.00%毛利率
60.20M总市值
-0.82回报/风险
4.93%风险率

即将为您带来更多新闻,敬请期待。。。
Talphera Inc评分
-0.01与上次评分对比预测8.00
财务诊断5.43
技术分析2.82
公司估值8.15
机构认同度3.00
风险评估3.63
分析师评级
买入评级
3.167目标均价
+170.66%涨幅空间
Talphera Inc 最新财报电话会记录
Talphera (TLPH) 2026年第二季度业绩电话会:NEPHRO CRRT入组率达到75%
Talphera 的 2026 年第二季度业绩电话会议涵盖了 NEPHRO CRRT 75% 的患者招募进度、1710 万美元现金、规模更大的美国市场预估以及其 2027 年 PMA 时间表。
财务指标
货币: USD

由于公司未披露,未能获取相关数据
货币: USD

由于公司未披露,未能获取相关数据
Talphera Inc 简介
Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company’s portfolio consists of nafamostat product candidates and pre-filled syringe product candidates. The Company’s lead product candidate, Niyad, is a lyophilized formulation of nafamostat and is being studied under an investigational device exemption (IDE) as an anticoagulant for the extracorporeal circuit. Niyad is used in adult patients undergoing continuous renal replacement therapy (CRRT). LTX-608 is its nafamostat formulation for direct IV infusion being explored as an investigational product for one or more indications, including antiviral treatment, or treatment of acute respiratory distress syndrome (ARDS) disseminated intravascular coagulation (DIC), or acute pancreatitis. The Company’s two ready-to-use pre-filled syringe (PFS) product candidates include Fedsyra and phenylephrine.
行业药品
公司代码TLPH
员工数量13
国家United States of America
持股情况
| 持股股东 | 占比 |
|---|
| CorMedix Inc | 17.52% |
|---|
| Rock Springs Capital Management LP | 6.92% |
|---|
| Rosalind Advisors, Inc. | 6.90% |
|---|
| AIGH Capital Management, LLC. | 6.55% |
|---|
| 股东类型 | 占比 |
|---|
| Corporation | 17.52% |
|---|
| Hedge Fund | 15.02% |
|---|
| Individual Investor | 6.73% |
|---|
| Private Equity | 6.55% |
|---|
常见问题
Talphera Inc(TLPH)的当前股价是多少?
Talphera Inc(TLPH)的当前股价是 1.16。
Talphera Inc股票的52周最高点是多少?
Talphera Inc股票的52周最高点是1.57。
Talphera Inc股票的52周最低点是多少?
Talphera Inc股票的52周最低点是0.69。
现在Talphera Inc(TLPH)的股票是买入、持有还是卖出?
根据分析师评级,Talphera Inc(TLPH)的总体评级为买入,目标价格为3.17。
Talphera Inc(TLPH)股票的每股收益(EPS TTM)是多少
Talphera Inc(TLPH)股票的每股收益(EPS TTM)是-0.27。